Valuations of many notable Indian start-ups, ranging from Byju's to Oyo, among others, have dropped by almost 50 per cent after the funding boom of 2021. with fortunes changing, raising capital is no cakewalk today as the battle now has moved to retaining investor confidence - Issue Date: Aug 06, 2023
Sahil Kanuga news: Read stories by Sahil Kanuga on The Economic Times. Read latest stories, expert columns, recommendations, best strategies, breaking story analysis by Sahil Kanuga.
PharmEasy has also come under scrutiny for acquiring massive debt. It borrowed $285 million from Goldman Sachs to pay off an earlier debt incurred from Kotak Mahindra Bank to buy Thyrocare
Sahil Kanuga is an attorney at Nishith Desai Assoc. India-centric Global Law Firm. Sahil has worked on an array of complex matters including Indian and international arbitrations, and he also advises multi-national clients involving issues such as internal fraud, anti-corruption, anti-bribery and data privacy.
Legal Disclaimer
You are responsible for reading, understanding and agreeing to the National Law Review s (NLR’s) and the National Law Forum LLC s Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.